Journal of thrombosis and haemostasis : JTH
Journal
Overview
publication venue for
-
Macrothrombosis and stroke in patients with mild Covid-19 infection.
2020
-
Hereditary Antithrombin Deficiency Pilot Project Registry from the American Thrombosis and Hemostasis Network (ATHN).
2024
-
Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort.
2023
-
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study..
21.
2022
-
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes..
20.
2022
-
Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH.
2022
-
ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort..
19.
2021
-
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients..
19.
2021
-
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation..
18.
2020
-
Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients..
18.
2020
-
Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency..
18.
2020
-
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository..
17.
2019
-
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC..
17.
2019
-
The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia..
17.
2019
-
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.
2018
-
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis..
15.
2017
-
Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes..
15.
2017
-
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study..
15.
2017
-
Hemostasis biomarkers and risk of sepsis: the REGARDS cohort..
14.
2016
-
Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital..
14.
2016
-
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity..
13.
2015
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings..
13.
2015
-
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis..
13.
2015
-
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia..
13.
2015
-
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging..
12.
2014
-
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa..
12.
2014
-
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura..
10.
2012
-
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia..
9.
2011
-
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation..
9.
2011
-
Innate immunity and coagulation..
9 Suppl 1.
2011
-
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion..
8.
2010
-
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies..
8.
2010
-
Pharmacokinetics and safety of fibrinogen concentrate..
7.
2009
-
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study..
7.
2009
-
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock..
7.
2009
-
Power Doppler sonography in the diagnosis of hemophilic synovitis--a promising tool..
6.
2008
-
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions..
6.
2008
-
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor..
6.
2008
-
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin..
5.
2007
-
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin..
5.
2007
-
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial..
3.
2005
-
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot..
2.
2004
-
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias..
2.
2004
-
Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation..
1.
2003
-
The international immune tolerance study: a multicenter prospective randomized trial in progress..
4.
2006
-
Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting.
2013
-
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal.
2010
-
Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis.
2006
-
Adverse effects of estrogen therapy in a subset of women with ITP.
2004
-
Megakaryocytes, malignancy and bone marrow vascular niches.
2012
-
Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia.
2009
-
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach.
2007
-
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
2009
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)